Costs of severely ill members and specialty medication use in a commercially insured population.

Costs of severely ill members and specialty medication use in a commercially insured population. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Costs of severely ill members and specialty medication use in a commercially insured population. Abstract Text:

This study examines the overall profile and costs associated with severely ill commercially insured people. We found severely ill members to have the highest costs, from both the insurer and member perspective. Even for the most costly members where specialty medication use was highest, biologics represented less than one-third of the pharmacy spending and 6.6 percent of overall spending. Out-of-pocket spending rose dramatically when medications were paid for under the pharmacy benefit rather than the medical benefit. The advantages of paying for specialty medications under the pharmacy benefit should be evaluated in conjunction with the potential consequences of increased out-of-pocket burden.

Costs of severely ill members and specialty medication use in a commercially insured population. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE: 2008 May-Jun

Costs of severely ill members and specialty medication use in a commercially insured population. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Health affairs (Project Hope)

VOLUME: 27

Page Numbers: 824-34

Journal Abbreviation:

ISSN: 1544-5208

DAY: 13

MONTH: 05

YEAR: 2008

Costs of severely ill members and specialty medication use in a commercially insured population. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8303128

Costs of severely ill members and specialty medication use in a commercially insured population. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Costs of severely ill members and specialty medication use in a commercially insured population. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Costs of severely ill members and specialty medication use in a commercially insured population.

AFFILIATION: Research Development and Operations, at HealthCore in Wilmington, Delaware, USA. vwilley@healthcore.com

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Health Aff (Millwood)

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Costs of severely ill members and specialty medication use in a commercially insured population Related Publications

• 1017.
• A comparison of two electric taste stimulation devices.
• A direct comparison of the taste of electrical and chemical stimuli.
• Beyond the myths: finding benefit design solutions that address the true costs of high healthcare use.
• CLINICAL THERMOMETERS.
• Costs of severely ill members and specialty medication use in a commercially insured population.
• Cultural and religious aspects of care in the intensive care unit within the context of patient-centred care.
• Customers care.
• Effects of a cyclooxygenase 2 inhibitor on fracture healing in a rat model.
• Introduction and Overview: 12: 9:30 AM-9:35 AM.
• Malnutrition and body temperature.
• Ocular emergencies.
• Persistence of context effects after training and with intensity references.
• Resuscitation in Athletes: Use of AED's and ICD's: 15: 10:25 AM-10:50 AM.
• Retronasal smell and detection thresholds of iron and copper salts.
• Self-injurious behavior in acquired sensory neuropathy.
• Use of silicone-treated test tubes to obtain serum from blood.